A formal peer-support program for medical providers affected by stress and trauma is gradually becoming a cultural norm for rheumatologists and other physicians at Johns Hopkins University…... [Read More]
Carina Stanton, BSJ, MA, is a freelance science journalist based in Denver. She has been writing about science for more than 16 years, covering a range of healthcare topics, including rheumatology, surgery, nursing and executive leadership. Her work has appeared in newspapers, newsletters, trade and consumer magazines, books and peer-reviewed journals. Carina has also covered a range of other science news topics, including environmental science, marine biology and archaeology. She has conducted her own research in historical archaeology in Great Britain and Scotland and worked on dig sites in Northern Ireland and Wales. As a former mass media science and engineering fellow for the American Association for the Advancement of Science, Carina is inspired to advance the public understanding of science. When she is not working indoors, Carina is happy spending time outside with her husband and two young children to hike, mountain bike and help her children grow their passion for nature.
Articles by Carina Stanton
Galectin-3 May Be a Biomarker for Cardiovascular Disease in RA
Galectin-3 may have potential as a biomarker for the early onset of cardiovascular disease in RA patients, potentially enabling early intervention and deferring the cardiovascular risks associated with RA…... [Read More]
Joining Forces to Advance Pediatric Rheumatology Care
Pediatric rheumatologists are in high demand. In fact, a shortage of pediatric rheumatologists requires more than half of all U.S. children with rheumatic diseases seek care with adult rheumatologists, and this shortage is projected to increase. For the past decade, the ACR’s Special Committee on Pediatric Rheumatology has worked to change this by bringing together… [Read More]
Bringing a Frontline Perspective to Insurance Advocacy
Early in his career as a resident at Washington University in St. Louis, Mo., Christopher Phillips, MD, felt a connection to his patients battling rheumatic diseases. Today, Dr. Phillips balances time with his solo private practice in Paducah, Ky., to help rheumatologists fight insurance battles for their patients in his role as chair of the… [Read More]
Large Vessel Vasculitis Outcome Measures: An Update from OMERACT
In ongoing work to validate data-driven outcome tools for clinical investigation in large vessel vasculitis, an international team of rheumatologists from the Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group has published a report on subclinical disease activity and patient perspectives on therapy response…... [Read More]
Practices Now Contributing to RheumPAC
Last year the ACR’s nonpartisan political action committee, RheumPAC, raised nearly $150,000 from individual contributors. Starting in 2019, the addition of the RheumPAC Advocacy Fund, where rheumatology practices and state societies can contribute corporate dollars, is expected to support RheumPAC fundraising efforts in an effort to surpass this dollar amount, giving rheumatology an even stronger… [Read More]
3 Tips to Optimize Practice Performance
Rheumatologists can build resilience through recovery and reframing, transforming stress so that it enhances performance…... [Read More]
History of Depression Is a Risk Factor for SLE in Women
Results from a 20-year, cohort study add to the evidence that depression increases the risk of developing an autoimmune disease, specifically SLE in women. Lead investigator Andrea Roberts, PhD, says, “There may be direct biological effects of depression that increase the risk of autoimmune disease.”…... [Read More]
The Effects of Early RA Treatment on CVD
New research exploring the effects of etanercept on cardiovascular disease in treatment-naive, early RA patients suggests a treatment advantage with etanercept, a TNF inhibitor and methotrexate over treatment with methotrexate and a conventional synthetic disease-modifying anti-rheumatic drug…... [Read More]
Large-Vessel Involvement Is an Independent Risk Factor Predicting GCA Mortality
At diagnosis, temporal artery biopsy results and large-vessel involvement of patients with giant cell arteritis may be stronger predictors of mortality than cardiovascular risk factors…... [Read More]
- 1
- 2
- 3
- …
- 9
- Next Page »